Magnet® Hospital Recognition Linked to Lower Central Line-Associated Bloodstream Infection Rates

被引:35
|
作者
Barnes, Hilary [1 ]
Rearden, Jessica [1 ]
McHugh, Matthew D. [2 ,3 ]
机构
[1] Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, 418 Curie Blvd,Room 388R, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Rosemarie Greco Term Endowed, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Nursing, Advocacy, Philadelphia, PA 19104 USA
关键词
magnet hospital; work environment; infection; nursing care; CLABSI; HAC reduction program; QUALITY IMPROVEMENT; NURSE OUTCOMES; PATIENT; MORTALITY; CARE; PREVENTION; MEDICARE;
D O I
10.1002/nur.21709
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Central-line-associated bloodstream infections (CLABSI) are among the deadliest heathcare-associated infections, with an estimated 12-25% mortality rate. In 2014, the Centers for Medicare and Medicaid Services (CMS) began to penalize hospitals for poor performance with respect to selected hospital-acquired conditions, including CLABSI. A structural factor associated with high-quality nursing care and better patient outcomes is The Magnet Recognition Program (R). The purpose of this study was to explore the relationship between Magnet status and hospital CLABSI rates. We used propensity score matching to match Magnet and non-Magnet hospitals with similar hospital characteristics. In a matched sample of 291 Magnet hospitals and 291 non-Magnet hospitals, logistic regression models were used to examine whether there was a link between Magnet status and CLABSI rates. Both before and after matching, Magnet hospital status was associated with better (lower than the national average) CLABSI rates (OR=1.60, 95%CI: 1.10, 2.33 after matching). While established programs such as Magnet recognition are consistently correlated with high-quality nursing work environments and positive patient outcomes, additional research is needed to determine whether Magnet designation produces positive patient outcomes or rewards existing excellence. (c) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 50 条
  • [31] Zero risk for central line-associated bloodstream infection: Are we there yet?
    McLaws, Mary-Louise
    Burrell, Anthony R.
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (02) : 388 - 393
  • [32] A Case of Munchausen Syndrome or Central Line-Associated Bloodstream Infection? Or Both?
    Zangwill, Kenneth M.
    Marin, Cristina
    Vu, Hailong
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (12): : 1550 - 1551
  • [33] Preventing Central Line-Associated Bloodstream Infection in Pediatric Oncology Care
    Duffy, Elizabeth A.
    Rabatin, Margaret
    [J]. AACN ADVANCED CRITICAL CARE, 2018, 29 (02) : 111 - 114
  • [34] Central Line-Associated Bloodstream Infection Risk Factors in a Pediatric Population
    Trembath, Hannah E.
    Caruso, Deanna M.
    McLean, Sean E.
    Akinkuotu, Adesola C.
    Hayes Dixon, Andrea A.
    Phillips, Michael R.
    [J]. AMERICAN SURGEON, 2024, 90 (01) : 69 - 74
  • [35] Reducing central line-associated bloodstream infection (CLABSI) rates with cognitive science-based training
    Lowery, Jessica
    Hays, Matthew Jensen
    Burch, Andrea
    Behr, Debra
    Brown, Steven
    Kearney, Elise
    Senseney, Deborah
    Arce, Sky
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2022, 50 (11) : 1266 - 1267
  • [36] Using a Comprehensive On-Site Assessment Process to Reduce Central Line-Associated Bloodstream Infection Rates
    Bartles, Rebecca
    Moore, Andria
    Martin, Rosemary
    Clarkson, Rebecca
    Ebinger, Laura
    [J]. JOURNAL OF INFUSION NURSING, 2023, 46 (05) : 266 - 271
  • [37] Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing
    Scheithauer, S.
    Lewalter, K.
    Schroeder, J.
    Koch, A.
    Haefner, H.
    Krizanovic, V.
    Nowicki, K.
    Hilgers, R. -D.
    Lemmen, S. W.
    [J]. INFECTION, 2014, 42 (01) : 155 - 159
  • [38] Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing
    S. Scheithauer
    K. Lewalter
    J. Schröder
    A. Koch
    H. Häfner
    V. Krizanovic
    K. Nowicki
    R.-D. Hilgers
    S. W. Lemmen
    [J]. Infection, 2014, 42 : 155 - 159
  • [39] Treatment of central line-associated bloodstream infections
    Jérémy Guenezan
    Bertrand Drugeon
    Nicolas Marjanovic
    Olivier Mimoz
    [J]. Critical Care, 22
  • [40] Incidence of Central Line-Associated Bloodstream Infection in a Tertiary Care Hospital in Northern India: A Prospective Study
    Maqbool, Safia
    Sharma, Rajni
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)